Connor, Clark & Lunn Investment Management (CC&L)
QNCX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Quince Therapeutics QNCX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,275
Closed -$23K – 1388
2022
Q3 		$23K Buy
+17,275
New +$23K ﹤0.01% 1078